ECIS European Commission. https://ecis.jrc.ec.europa.eu/. Accessed 01 Mar 2018.
Galceran J, Ameijide A, Carulla M, Mateos A, Quirós JR, Rojas D, et al. Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017;19:799–825.
Article
CAS
PubMed
Google Scholar
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
Article
PubMed
Google Scholar
WHO. Globocan 2012—Home [Internet]. Globocan 2012. 2012. http://globocan.iarc.fr/Default.aspx. Accessed 1 Mar 2018.
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–75.
Article
PubMed
PubMed Central
Google Scholar
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15:23–34.
Article
PubMed
Google Scholar
Chirlaque MD, Salmerón D, Galceran J, Ameijide A, Mateos A, Torrella A, et al. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries. Clin Transl Oncol. 2018;20(2):201–11.
Article
CAS
PubMed
Google Scholar
Wong MCS, Lao XQ, Ho K-F, Goggins WB, Tse SLA. Incidence and mortality of lung cancer: global trends and association with socioeconomic status. Sci Rep. 2017;7:14300.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest. 2004;125:27–37.
Article
PubMed
Google Scholar
Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest. 2004;126:347–51.
Article
PubMed
Google Scholar
Tan YK, Wee TC, Koh WP, Wang YT, Eng P, Tan WC, et al. Survival among Chinese women with lung cancer in Singapore: a comparison by stage, histology and smoking status. Lung Cancer. 2003;40:237–46.
Article
CAS
PubMed
Google Scholar
Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer. 1999;86:1867–76.
Article
CAS
PubMed
Google Scholar
Alberts WM. Diagnosis and management of lung cancer executive summary: aCCP evidence-based clinical practice guidelines. Chest. 2007;132:1S–19S (2nd edition).
Article
PubMed
Google Scholar
Xie L, Ugnat A-M, Morriss J, Semenciw R, Mao Y. Histology-related variation in the treatment and survival of patients with lung carcinoma in Canada. Lung Cancer. 2003;42:127–39.
Article
PubMed
Google Scholar
Salmerón D, Chirlaque MD, Isabel Izarzugaza M, Sánchez MJ, Marcos-Gragera R, Ardanaz E, et al. Lung cancer prognosis in Spain: the role of histology, age and sex. Respir Med. 2012;106:1301–8.
Article
PubMed
Google Scholar
Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. 2006;17:5–19.
Article
CAS
PubMed
Google Scholar
Viñas Casasola MJ, Fernández Navarro P, Fajardo Rivas ML, Gurucelain Raposo JL, Alguacil Ojeda J. Distribución municipal de la incidencia de los tumores más frecuentes en un área de elevada mortalidad por cáncer. Gac Sanit. 2017;31:100–7.
Article
PubMed
Google Scholar
De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003;56:221–9.
Article
PubMed
Google Scholar
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
Article
CAS
PubMed
Google Scholar
Perme MP, Stare J, Esteve J. On estimation in relative survival. Biometrics. 2012;68:113–20.
Article
PubMed
Google Scholar
Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004;40:2307–16.
Article
PubMed
Google Scholar
Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23:51–64.
Article
PubMed
Google Scholar
StataCorp. Stata statistical software: release 12. College Station: StataCorp LP; 2011.
Google Scholar
Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grimsrud TK, et al. Survival patterns in lung and pleural cancer in Europe 1999-2007: results from the EUROCARE-5 study. Eur J Cancer. 2015;51:2242–53.
Article
PubMed
Google Scholar
Aggarwal C, Langer CJ. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer. Curr Opin Oncol. 2012;24:130–6.
Article
PubMed
Google Scholar
Lembicz M, Gabryel P, Brajer-Luftmann B, Dyszkiewicz W, Batura-Gabryel H. Comorbidities with non-small cell lung cancer: is there an interdisciplinary consensus needed to qualify patients for surgical treatment? Ann Thorac Med. 2018;13:101–7.
Article
PubMed
PubMed Central
Google Scholar
Sacher AG, Dahlberg SE, Heng J, Mach S, Jänne PA, Oxnard GR. Lung cancer diagnosed in the young is associated with enrichment for targetable genomic alterations and poor prognosis HHS Public Access. JAMA Oncol. 2016;1:313–20.
Article
Google Scholar
De Leyn P, Moons J, Vansteenkiste J, Verbeken E, Van Raemdonck D, Nafteux P, et al. Survival after resection of synchronous bilateral lung cancer. Eur J Cardio Thorac Surg. 2008;34:1215–22.
Article
Google Scholar
Tsunezuka Y, Matsumoto I, Tamura M, Oda M, Ohta Y, Shimizu J, et al. The results of therapy for bilateral multiple primary lung cancers: 30 years experience in a single centre. Eur J Surg Oncol. 2004;30:781–5.
Article
CAS
PubMed
Google Scholar
Mun M, Kohno T. Single-stage surgical treatment of synchronous bilateral multiple lung cancers. Ann Thorac Surg. 2007;83:1146–51.
Article
PubMed
Google Scholar
Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels ABB, Maisonneuve P, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer. 2008;122:155–64.
Article
CAS
PubMed
Google Scholar
Sánchez-Cruz JJ, García LI, Mayoral JM. Encuesta andaluza de salud 2015–2016 de Adultos. Sevilla: Consejería de Salud. Junta de Andalucía; 2016.
Google Scholar
Galceran J, Amejeide A, Carulla M, Mateps A, Quirós JR, Alemán A, et al. Estimaciones de la incidencia y la supervivencia del cáncer en españa y su situación en europa. Red Española de Registros de Cáncer. 2014;1–58.
Fu JB, Kau TY, Severson RK, Kalemkerian GP. Lung cancer in women: analysis of the national surveillance, epidemiology, and end results database. Chest. 2005;127:768–77.
Article
PubMed
Google Scholar
Moore R, Doherty D, Chamberlain R, Khuri F. Sex differences in survival in non-small cell lung cancer patients 1974-1998. Acta Oncol. 2004;43:57–64.
Article
PubMed
Google Scholar
Wisnivesky JP, Halm EA. Sex differences in lung cancer survival: do tumors behave differently in elderly women? J Clin Oncol. 2007;25:1705–12.
Article
PubMed
Google Scholar
Micheli A, Ciampichini R, Oberaigner W, Ciccolallo L, de Vries E, Izarzugaza I, et al. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer. 2009;45:1017–27.
Article
CAS
PubMed
Google Scholar
Skuladottir H, Olsen JH. Can reproductive pattern explain better survival of women with lung cancer? Acta Oncol. 2006;45:47–53.
Article
PubMed
Google Scholar
Redondo-Sendino A, Guallar-Castillón P, Banegas JR, Rodríguez-Artalejo F. Gender differences in the utilization of health-care services among the older adult population of Spain. BMC Public Health. 2006;6:155.
Article
PubMed
PubMed Central
Google Scholar
Salomaa E-R, Sallinen S, Hiekkanen H, Liippo K. Delays in the diagnosis and treatment of lung cancer. Chest. 2005;128:2282–8.
Article
PubMed
Google Scholar
Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer. 2009;45:931–91.
Article
PubMed
Google Scholar
Shroff GS, de Groot PM, Papadimitrakopoulou VA, Truong MT, Carter BW. Targeted Therapy and Immunotherapy in the Treatment of Non-Small Cell Lung Cancer. Radiol Clin North Am. 2018;56:485–95.
Article
PubMed
Google Scholar
Nishinarita N, Igawa S, Kasajima M, Kusuhara S, Harada S, Okuma Y, et al. Smoking History as a predictor of epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring EGFR mutations. Oncology. 2018;95(2):109–15.
Article
CAS
PubMed
Google Scholar